Generation and analysis of the improved human HAL9/10 antibody phage display libraries. 2015

Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Spielmannstr. 7, 38106, Braunschweig, Germany. jonas.kuegler@tu-bs.de.

BACKGROUND Antibody phage display is a proven key technology that allows the generation of human antibodies for diagnostics and therapy. From naive antibody gene libraries - in theory - antibodies against any target can be selected. Here we describe the design, construction and characterization of an optimized antibody phage display library. RESULTS The naive antibody gene libraries HAL9 and HAL10, with a combined theoretical diversity of 1.5×10(10) independent clones, were constructed from 98 healthy donors using improved phage display vectors. In detail, most common phagemids employed for antibody phage display are using a combined His/Myc tag for detection and purification. We show that changing the tag order to Myc/His improved the production of soluble antibodies, but did not affect antibody phage display. For several published antibody libraries, the selected number of kappa scFvs were lower compared to lambda scFvs, probably due to a lower kappa scFv or Fab expression rate. Deletion of a phenylalanine at the end of the CL linker sequence in our new phagemid design increased scFv production rate and frequency of selected kappa antibodies significantly. The HAL libraries and 834 antibodies selected against 121 targets were analyzed regarding the used germline V-genes, used V-gene combinations and CDR-H3/-L3 length and composition. The amino acid diversity and distribution in the CDR-H3 of the initial library was retrieved in the CDR-H3 of selected antibodies showing that all CDR-H3 amino acids occurring in the human antibody repertoire can be functionally used and is not biased by E. coli expression or phage selection. Further, the data underline the importance of CDR length variations. CONCLUSIONS The highly diverse universal antibody gene libraries HAL9/10 were constructed using an optimized scFv phagemid vector design. Analysis of selected antibodies revealed that the complete amino acid diversity in the CDR-H3 was also found in selected scFvs showing the functionality of the naive CDR-H3 diversity.

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D057127 Single-Chain Antibodies A form of antibodies consisting only of the variable regions of the heavy and light chains (FV FRAGMENTS), connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use. Fv Antibody Fragments, Single-Chain,ScFv Antibodies,Single-Chain Fv,Single-Chain Fv Antibody,Single-Chain Fv Antibody Fragments,Single-Chain Variable Fragment,Single-Chain Variable Fragment Antibodies,Single-Chain Variable Fragment Antibody,Single-Chain Variable Fragments,Antibodies, ScFv,Antibodies, Single-Chain,Antibody, Single-Chain Fv,Fragment, Single-Chain Variable,Fragments, Single-Chain Variable,Fv Antibody Fragments, Single Chain,Fv Antibody, Single-Chain,Fv, Single-Chain,Single Chain Antibodies,Single Chain Fv,Single Chain Fv Antibody,Single Chain Fv Antibody Fragments,Single Chain Variable Fragment,Single Chain Variable Fragment Antibodies,Single Chain Variable Fragment Antibody,Single Chain Variable Fragments,Variable Fragment, Single-Chain,Variable Fragments, Single-Chain
D019151 Peptide Library A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide. Phage Display Peptide Library,Random Peptide Library,Peptide Phage Display Library,Phage Display Library, Peptide,Synthetic Peptide Combinatorial Library,Synthetic Peptide Library,Libraries, Peptide,Libraries, Random Peptide,Libraries, Synthetic Peptide,Library, Peptide,Library, Random Peptide,Library, Synthetic Peptide,Peptide Libraries,Peptide Libraries, Random,Peptide Libraries, Synthetic,Peptide Library, Random,Peptide Library, Synthetic,Random Peptide Libraries,Synthetic Peptide Libraries

Related Publications

Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
April 2024, Cold Spring Harbor protocols,
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 2014, Methods in molecular biology (Clifton, N.J.),
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 2009, Methods in molecular biology (Clifton, N.J.),
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 2012, Methods in molecular biology (Clifton, N.J.),
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
August 1997, Current opinion in biotechnology,
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
August 2019, International journal of biological macromolecules,
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 1995, Methods in molecular biology (Clifton, N.J.),
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
December 1996, Molecular biotechnology,
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 1998, Methods in molecular biology (Clifton, N.J.),
Jonas Kügler, and Sonja Wilke, and Doris Meier, and Florian Tomszak, and André Frenzel, and Thomas Schirrmann, and Stefan Dübel, and Henk Garritsen, and Björn Hock, and Lars Toleikis, and Mark Schütte, and Michael Hust
January 2018, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!